Mitigating tuberculosis risk among workers operating in the oil and gas sector

In the oil and gas industry, workforces live and work in confined environments, are globally mobile, and include people from countries with high tuberculosis (TB) prevalence. In response, the Company established a comprehensive program in the late 1990's to minimize TB transmission and prevent active cases in the workplace.

The tuberculosis program aligns with the global STOP TB approach while addressing local health regulations and guidelines. We continuously enroll and periodically screen workers operating offshore. Business travelers and expatriates going to locations with TB rates significantly different from their country of origin are periodically screened. The safety processes and tools raise awareness and enroll targeted workers for TB screening, contribute to the early detection of latent TB and allow specific follow-up procedures. Screening includes a questionnaire, physical examination, and testing. The company ensures appropriate treatment evaluation for both latent and active TB through external medical providers.

Since 2006, we performed 8,953 tests in the United States and successfully transitioned from tuberculin skin tests to the new and more efficient interferon gamma release assay (IGRA); overall, 3.9% of tests were positive and active TB is ruled out through defined procedures.

Integrating the TB program into existing company safety and health procedures and establishing business partnerships for TB services and supplies has assured effective implementation and continuous improvements, such as the introduction of new technologies and approaches.